ai guidance for biopsy in suspected cholangiocarcinoma

Conditions: Neoplasms; Non-Neoplastic; Bile Duct Neoplasms; Bile Duct Lesions

Summary: digital single-operator cholangioscopy (dsoc) has emerged as a medical advance with an important role in the evaluation of indeterminate biliary lesions. this technique has demonstrated higher sensitivity in the guidance for tissue acquisition when compared with standard endoscopic retrograde cholangiopancreatography (ercp). dsoc-guided biopsy is considered technically safe and successful for tissue collection. hand in hand with the development of more precise diagnostic techniques, comes the implementation of artificial intelligence (ai) for diagnostic assessment. for the past decade, the role of artificial intelligence (ai) has been increasing at a rapid pace. in the biliary tract, different models have been proposed for the characterization of malignant features. nevertheless, to date, the discrepancy between the visual impression of the operator and the histological results obtained by cholangioscopy still present, affecting the accuracy the diagnosis. based on the above, the investigators aim to assess the diagnostic accuracy of ai for the guidance of tissue acquisition with dsoc compared to dsoc without ai for suspected cholangiocarcinoma. as a secondary aim, the investigators pursue to compare quality of ai-guided biopsies samples vs. dsoc biopsies without ai.

the diagnosis and management of biliary malignancy currently represents a medical challenge. to date, dsoc has demonstrated high sensitivity in the detection of malignant biliary lesions, nevertheless there is not a universal expert consensus for the characterization of this lesions. also, dsoc has shown to be safe and successful for specimen collection with higher sensitivity when compared with standard ercp. moreover, most of the ai models proposed for characterization of neoplastic features in biliary lesions have demonstrated high reliability during dsoc performance. a model was the proposed by investigators in ecuador, focused on the identification of features of malignancy. the detection is performed by surrounding the suspected lesion in a bounding box. the detected area is displayed in the right side of the screen. also, the box/image of the presumptive lesion can also be recorded and reviewed afterwards. after the ai model detects the "malignant area", a tissue sample is collected and taken for histopathological studies. in addition, due to a variation of the endoscopists´ intra and interobserver agreement and the discrepancy between the visual impression and histopathological findings, the investigators intend to take advantage of our ai model as a diagnostic tool for a more precise acquisition of tissue in lesions suggestive of malignancy during real-time dsoc.

Eligibility criteria:
inclusion criteria: * patients referred to our center with an indication of dsoc due to suspicion of cbd tumor or indeterminate cbd stenosis. * patients who authorized for dsoc-guided biopsy. exclusion criteria: * any clinical condition which makes dsoc inviable. * patients with more than one dsoc. * lost on a six-month follow-up after dsoc.

Keywords: artificial intelligence cholangioscopy cholangiocarcinoma biopsy